Updated hourlyHourly refreshSun, Sep 6, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Healthcare
WAYNE, Pa., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced the grant of inducement equity awards to six new employees. The Compensation Committee of the Board of Directors of Avalo approved the grants of nonstatutory stock options to purchase an aggregate of 78,000 shares of common stock (the “Options”) as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
Sep 4 · 20:05·GlobeNewswire
Finance
CAMBRIDGE, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that on September 1, 2026, it awarded inducement grants to 41 new employees under Intellia’s 2024 Inducement Plan, as amended, as a material inducement to employment.
Sep 4 · 20:05·GlobeNewswire
Finance · Healthcare
New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us. You may...
Sep 4 · 20:05·mlpr-newsfile
Finance
NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast link available at Nasdaq’s Investor Relations website: https://ir.nasdaq.com/ .
Sep 4 · 20:05·GlobeNewswire
Finance · Energy
BOCA RATON, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. ("NOMAD" or the "Company") (Nasdaq: NMAD) (formerly LIXTE Biotechnology Holdings), a provider of transportable, utility-grade battery energy storage systems through its wholly owned subsidiary NOMAD Transportable Power Systems, today announced that the Company’s Special Meeting of Stockholders (the “Special Meeting”), originally convened at 1:00 PM Eastern Time on September 4, 2026, was adjourned without conducting any business and will reconvene on October 2, 2026 at 1:00 PM Eastern Time, in order to provide the Company additional time to complete and finalize its Nasdaq listing application.
Sep 4 · 20:05·GlobeNewswire
Finance
Opendoor Home Loans now offers 30-, 20-, and 15-year fixed-rate mortgages, plus 5/6, 7/6, 10/6 adjustable-rate mortgages for any home purchase in markets where Opendoor Home Loans is licensed. Opendoor Home Loans now offers 30-, 20-, and 15-year fixed-rate mortgages, plus 5/6, 7/6, 10/6 adjustable-rate mortgages for any home purchase in markets where Opendoor Home Loans is licensed.
Sep 4 · 20:05·GlobeNewswire
Finance
LEXINGTON, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced plans to participate in the following upcoming investor conferences:
Sep 4 · 20:05·GlobeNewswire
Finance
RUSH ENTERPRISES AND MCT COMPANIES COMPLETE FORMATION OF STRATEGIC JOINT VENTURE
Sep 4 · 20:05·GlobeNewswire
Finance
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 4 · 20:05·GlobeNewswire
Finance · Healthcare
BOSTON, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on September 1, 2026, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 83,600 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 17,900 shares of Vor Bio’s common stock to 6 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).
Sep 4 · 20:05·GlobeNewswire
In the wire
Delta, British Columbia--(Newsfile Corp. - September 4, 2026) - WestBond Enterprises Corporation (TSXV: WBE) is pleased to report that all matters were approved at the Company's Annual General shareholders meeting (the "Meeting") held on September 3, 2026. At the Meeting the Company's shareholders re-elected all of the Company's current board of directors, Gennaro Magistrale, J. Douglas Seppala, D. Dan Dawson and Walter Robert Lee as well as approved the re-appointment of the Company's current...
Sep 4 · 20:05·mlpr-newsfile
Finance
trivago N.V.: Brandon Pedersen, Vesting of Restricted Share Units.
Sep 4 · 20:02·GlobeNewswire